1.
Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss Med Wkly [Internet]. 2020 May 13 [cited 2025 Oct. 14];150(1920):w20223. Available from: https://smw.ch/index.php/smw/article/view/2791